These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29681625)

  • 21. Profile of the inflammatory bowel disease patient with depressive disorders.
    Acosta-Ramírez D; Pagán-Ocasio V; Torres EA; Rodríguez M; Caro O
    P R Health Sci J; 2001 Sep; 20(3):215-20. PubMed ID: 11776721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to Arteaga et al.
    Naicker K; Øverland S; Colman I
    Psychoneuroendocrinology; 2018 Mar; 89():257. PubMed ID: 29203078
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon-alpha-induced depression: A reply to the letters to the editor by Mahajan et al. and Porcelli et al.
    Baranyi A
    Psychother Psychosom; 2014; 83(5):312. PubMed ID: 25116854
    [No Abstract]   [Full Text] [Related]  

  • 24. Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease.
    Kovács Z; Kovács F
    Int J Psychiatry Med; 2007; 37(3):245-55. PubMed ID: 18314852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New treatment options for inflammatory bowel diseases.
    Verstockt B; Ferrante M; Vermeire S; Van Assche G
    J Gastroenterol; 2018 May; 53(5):585-590. PubMed ID: 29556726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise and depression: where do we go from here? A rebuttal to Schuch et al.
    Legrand FD; Neff E
    Acta Neuropsychiatr; 2017 Apr; 29(2):122-123. PubMed ID: 27919302
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to Cubala et al.
    Kwon OY
    Epilepsy Behav; 2018 Oct; 87():250-251. PubMed ID: 30033155
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comorbidity in connection with psoriasis is more than psoriatic arthritis].
    Kvist-Hansen A; Kaiser H; Skov L; Hansen PR
    Ugeskr Laeger; 2018 Jan; 180(2):. PubMed ID: 29368688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kirsch et al.'s (2008) calculations are correct: reconsidering Fountoulakis & Möller's re-analysis of the Kirsch data.
    Huedo-Medina TB; Johnson BT; Kirsch I
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1193-8. PubMed ID: 22433169
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter to the Editor: A comment on Borrione et al.
    Ortiz A
    Psychiatry Res; 2018 Dec; 270():1173. PubMed ID: 30041893
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychiatric illnesses in inflammatory bowel diseases - psychiatric comorbidity and biological underpinnings.
    Nowakowski J; Chrobak AA; Dudek D
    Psychiatr Pol; 2016 Dec; 50(6):1157-1166. PubMed ID: 28211554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to: 'Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease' by Orlando
    Varkas G; Van den Bosch F; Elewaut D
    Ann Rheum Dis; 2017 Sep; 76(9):e32. PubMed ID: 28183720
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being.
    Walker JR; Graff LA; Dutz JP; Bernstein CN
    J Rheumatol Suppl; 2011 Nov; 88():31-5. PubMed ID: 22045976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT): response to Bogner et al.
    Thombs BD; Ziegelstein RC
    Diabetes Care; 2008 Jun; 31(6):e54; author reply e55. PubMed ID: 18509141
    [No Abstract]   [Full Text] [Related]  

  • 35. Capsule Commentary on Gallo et al., Multimorbidity, Depression, and Mortality in Primary Care: Randomized Clinical Trial of an Evidence-Based Depression Care Management Program on Mortality Risk.
    Jackson JL; Kay C
    J Gen Intern Med; 2016 Apr; 31(4):412. PubMed ID: 26857728
    [No Abstract]   [Full Text] [Related]  

  • 36. Summing up: quality of life in chronic immune-mediated inflammatory diseases.
    Bernstein CN
    J Rheumatol Suppl; 2011 Nov; 88():62-5. PubMed ID: 22045981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Depressive and anxiety symptoms, coping strategies in patients with irritable bowel syndrome and inflammatory bowel disease].
    Kovács Z; Kovács F
    Psychiatr Hung; 2007; 22(3):212-21. PubMed ID: 18167418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to comment on Schmitz et al. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes care 2014;37:970-978.
    Schmitz N; Gariépy G; Smith KJ; Clyde M; Malla A; Boyer R; Strychar I; Lesage A; Wang J
    Diabetes Care; 2014 Jun; 37(6):e146-7. PubMed ID: 24855175
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to Villanacci et. al.
    Bryant RV; Winer S; Travis SP; Riddell RH
    J Crohns Colitis; 2015 May; 9(5):429. PubMed ID: 25761770
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics: response to Fisher et al.
    Vale S
    Diabetes Care; 2007 Jul; 30(7):e73; author reply e74. PubMed ID: 17596496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.